
KRM Ayurveda Ltd IPO Price Range is ₹128 - ₹135, with a minimum investment of ₹2,70,000 for 2000 shares per lot.
Minimum Investment
₹2,70,000
/ 2000 shares
IPO Status
Pre-application open
Price Band
₹128 - ₹135
Bidding Dates
Jan 21, 2026 - Jan 23, 2026
Issue Size
₹77.49 Cr
Lot Size
1000 shares
Min Investment
₹2,70,000
Listing Exchange
NSE
Designing and execution capabilities.
Experienced management team and a motivated and efficient work force.
Cordial relations with our consumers.
Quality assurance and control.
The companys Registered Office and other hospital premises from where the company operates are not owned by the company. If the companyare required to vacate the same, due to any reason whatsoever, it may adversely affect its businessoperations.
The Company has experienced, and may continue to experience, a higher rate of employee attrition inrecent periods, including among frontline and technical staff.
Majority of its state wise revenues from operations for the last 3 years is majorly derived from the companysTop 2 States. Any adverse developments affecting its operations in this state could have an adverseimpact on the companys revenue and results of operations.
The companys business is working capital intensive, and fluctuations or inadequate financing of its working capitalrequirements may adversely affect the companys business, financial condition, and results of operations.
The company is dependents on third-party transportation service providers for delivery of its raw materials and finishedproducts. Any disruption in such transportation arrangements or increase in transportation costs maymaterially and adversely affect the companys business, financial condition, results of operations, and cash flows
Conflicts of interest may arise out of common business undertaken by the Company and its promoter.
The provision of healthcare services involves high costs such as employee benefit expenses, rent andfacility fees, retainers and consultants fee and purchase of equipment and consumables, which the company mayfails to pass on to patients, which could adversely affect its business, results of operations and financialcondition.
A significant portion of its revenue is derived from patients who avail the companys hospital services throughinsurance providers. Any adverse change in the relationship with such insurers, delay in settlement ofclaims, or reduction in reimbursement rates may materially and adversely affect its business, financialcondition, results of operations, and cash flows.
The intend to use a portion of the Net Proceeds to prepay / repay in full or in part, of certain borrowingsavailed by the Company
Declining Reimbursement Rates from insurance providers may affect its financial position.